Retour
Fourchette du Jour
94,24 €
97,79 €
Fourchette 52 Semaines
55,54 €
113,02 €
Volume
483 457
Moyenne 50J / 200J
102,59 €
/
91,47 €
Clôture Précédente
94,77 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -16,6 | 0,4 |
| P/B | 5,7 | 2,9 |
| ROE % | -36,7 | 3,8 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
137,44 €
+42.5%
Low: 120,00 €
High: 155,00 €
BPA Prévisionnel
-5,56 €
CA Est.
14 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
6,16 €
1,30 € – 12,24 €
|
1,3 B | 5 |
| FY2029 |
3,26 €
0,69 € – 6,48 €
|
930 M | 10 |
| FY2028 |
-0,93 €
-4,47 € – 2,94 €
|
530 M | 12 |
Points Clés
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -275,21M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-36,70%
ROIC-24,89%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,00
Current Ratio15,27
Interest Coverage0,00
Valorisation
P/E Ratio
-16,59
P/B Ratio5,65
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -425,38M |
| ROE | -36,70% | ROA | -30,11% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -275,21M |
| ROIC | -24,89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 15,27 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -16,59 | P/B Ratio | 5,65 |
| P/S Ratio | N/A | PEG Ratio | -0,35 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 7,06B | Enterprise Value | 6,80B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -425,38M | -260,76M | -126,22M | -81,85M | -46,34M |
| EPS (Diluted) | -5,85 | -3,93 | -2,17 | -1,65 | -2,13 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -414,31M | -280,37M | -149,49M | -86,11M | -45,82M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,41B | 1,14B | 732,38M | 482,46M | 293,82M |
| Total Liabilities | 164,37M | 71,96M | 31,82M | 19,48M | 8,79M |
| Shareholders' Equity | 1,25B | 1,07B | 700,56M | 462,98M | 285,04M |
| Total Debt | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Cash & Equivalents | 261,75M | 145,69M | 335,39M | 241,81M | 68,53M |
| Current Assets | 1,39B | 1,13B | 726,49M | 477,99M | 290,63M |
| Current Liabilities | 91,17M | 54,02M | 31,82M | 19,48M | 8,79M |